Published in Spine (Phila Pa 1976) on December 01, 2007
Alterations in chondroitin sulfate proteoglycan expression occur both at and far from the site of spinal contusion injury. Exp Neurol (2011) 1.00
A re-assessment of erythropoietin as a neuroprotective agent following rat spinal cord compression or contusion injury. Exp Neurol (2008) 0.91
Genome-wide gene expression profiling of stress response in a spinal cord clip compression injury model. BMC Genomics (2013) 0.86
Human bone marrow-derived and umbilical cord-derived mesenchymal stem cells for alleviating neuropathic pain in a spinal cord injury model. Stem Cell Res Ther (2016) 0.82
Improved rat spinal cord injury model using spinal cord compression by percutaneous method. J Vet Sci (2013) 0.79
A New Acute Impact-Compression Lumbar Spinal Cord Injury Model in the Rodent. J Neurotrauma (2015) 0.78
Electroacupuncture in the repair of spinal cord injury: inhibiting the Notch signaling pathway and promoting neural stem cell proliferation. Neural Regen Res (2015) 0.78
Synergetic use of neural precursor cells and self-assembling peptides in experimental cervical spinal cord injury. J Vis Exp (2015) 0.77
The immunomodulator decoy receptor 3 improves locomotor functional recovery after spinal cord injury. J Neuroinflammation (2016) 0.75
Arachidonic acid pathway alterations in cerebrospinal fluid of dogs with naturally occurring spinal cord injury. BMC Neurosci (2016) 0.75
Comparative assessment of phototherapy protocols for reduction of oxidative stress in partially transected spinal cord slices undergoing secondary degeneration. BMC Neurosci (2016) 0.75
Cornel Iridoid Glycoside Improves Locomotor Impairment and Decreases Spinal Cord Damage in Rats. Biomed Res Int (2016) 0.75
Identification of temporal genes involved in the mechanisms of spinal cord injury. Spinal Cord (2017) 0.75
IKVAV-linked cell membrane-spanning peptide treatment induces neuronal reactivation following spinal cord injury. Future Sci OA (2015) 0.75
Potential variables affecting the quality of animal studies regarding pathophysiology of traumatic spinal cord injuries. Spinal Cord (2015) 0.75
Neurophysiological monitoring during acute and progressive experimentally induced compression injury of the spinal cord in pigs. Eur Spine J (2015) 0.75
Host reaction to poly(2-hydroxyethyl methacrylate) scaffolds in a small spinal cord injury model. J Mater Sci Mater Med (2013) 0.75
Consensus statement on concussion in sport: the 4th International Conference on Concussion in Sport held in Zurich, November 2012. Br J Sports Med (2013) 6.69
A photolabile hydrogel for guided three-dimensional cell growth and migration. Nat Mater (2004) 3.29
Spatially controlled simultaneous patterning of multiple growth factors in three-dimensional hydrogels. Nat Mater (2011) 2.54
Surgical management of tethered cord syndrome in adults: indications, techniques, and long-term outcomes in 60 patients. J Neurosurg Spine (2006) 2.43
The effect of substrate stiffness on adult neural stem cell behavior. Biomaterials (2009) 1.91
Peripheral nerve regeneration through guidance tubes. Neurol Res (2004) 1.71
Examining Ontario deaths due to all-terrain vehicles, and targets for prevention. Can J Neurol Sci (2010) 1.52
Consensus statement on concussion in sport--the 4th International Conference on Concussion in Sport held in Zurich, November 2012. Clin J Sport Med (2013) 1.50
Immobilized concentration gradients of nerve growth factor guide neurite outgrowth. J Biomed Mater Res A (2004) 1.41
Consensus statement on concussion in sport: the 4th International Conference on Concussion in Sport, Zurich, November 2012. J Athl Train (2013) 1.36
Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells. Acta Biomater (2008) 1.34
Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord. Biomaterials (2005) 1.32
Guided cell adhesion and outgrowth in peptide-modified channels for neural tissue engineering. Biomaterials (2005) 1.26
Advances in stem cell therapy for spinal cord injury. J Clin Invest (2012) 1.24
Transplantation of adult rat spinal cord stem/progenitor cells for spinal cord injury. J Neurotrauma (2007) 1.21
Particles for multiplexed analysis in solution: detection and identification of striped metallic particles using optical microscopy. Anal Chem (2002) 1.21
Design of three-dimensional biomimetic scaffolds. J Biomed Mater Res A (2010) 1.18
Colloidal aggregation affects the efficacy of anticancer drugs in cell culture. ACS Chem Biol (2012) 1.17
A prospective study of physician-observed concussions during junior ice hockey: implications for incidence rates. Neurosurg Focus (2010) 1.14
Motor and sensory assessment of patients in clinical trials for pharmacological therapy of acute spinal cord injury: psychometric properties of the ASIA Standards. J Neurotrauma (2008) 1.12
Regenerative biomaterials that "click": simple, aqueous-based protocols for hydrogel synthesis, surface immobilization, and 3D patterning. Bioconjug Chem (2011) 1.10
Synthetic hydrogel guidance channels facilitate regeneration of adult rat brainstem motor axons after complete spinal cord transection. J Neurotrauma (2004) 1.09
Fibrin-filled scaffolds for bone-tissue engineering: An in vivo study. J Biomed Mater Res A (2004) 1.09
Controlling cell adhesion and degradation of chitosan films by N-acetylation. Biomaterials (2005) 1.09
Synthesis of enzyme-degradable, peptide-cross-linked dextran hydrogels. Bioconjug Chem (2007) 1.09
Stability of Self-Assembled Polymeric Micelles in Serum. Macromolecules (2011) 1.08
Absence of chronic traumatic encephalopathy in retired football players with multiple concussions and neurological symptomatology. Front Hum Neurosci (2013) 1.07
Intrathecal administration of epidermal growth factor and fibroblast growth factor 2 promotes ependymal proliferation and functional recovery after spinal cord injury in adult rats. J Neurotrauma (2002) 1.05
Colloidal drug formulations can explain "bell-shaped" concentration-response curves. ACS Chem Biol (2014) 1.04
Injectable hydrogels for central nervous system therapy. Biomed Mater (2012) 1.03
Bioengineered strategies for spinal cord repair. J Neurotrauma (2006) 1.03
Does the apolipoprotein epsilon 4 allele predispose varsity athletes to concussion? A prospective cohort study. Clin J Sport Med (2008) 1.03
Differentiation of neural stem cells in three-dimensional growth factor-immobilized chitosan hydrogel scaffolds. Biomaterials (2010) 1.02
Fiber templating of poly(2-hydroxyethyl methacrylate) for neural tissue engineering. Biomaterials (2003) 1.02
The use of vascular endothelial growth factor functionalized agarose to guide pluripotent stem cell aggregates toward blood progenitor cells. Biomaterials (2010) 1.01
Matrix inclusion within synthetic hydrogel guidance channels improves specific supraspinal and local axonal regeneration after complete spinal cord transection. Biomaterials (2005) 1.00
Macroporous interconnected dextran scaffolds of controlled porosity for tissue-engineering applications. Biomaterials (2005) 1.00
Return to play after an initial or recurrent concussion in a prospective study of physician-observed junior ice hockey concussions: implications for return to play after a concussion. Neurosurg Focus (2010) 0.99
Consensus statement on concussion in sport: the 4th International Conference on Concussion in Sport held in Zurich, November 2012. J Am Coll Surg (2013) 0.99
Adult spinal cord stem/progenitor cells transplanted as neurospheres preferentially differentiate into oligodendrocytes in the adult rat spinal cord. Cell Transplant (2008) 0.99
Bioengineered sequential growth factor delivery stimulates brain tissue regeneration after stroke. J Control Release (2013) 0.98
Review of transplantation of neural stem/progenitor cells for spinal cord injury. Int J Dev Neurosci (2013) 0.98
A hydrogel-based stem cell delivery system to treat retinal degenerative diseases. Biomaterials (2010) 0.97
Incidence and severity of acute complications after spinal cord injury. J Neurosurg Spine (2012) 0.97
Oligodendrocytes and radial glia derived from adult rat spinal cord progenitors: morphological and immunocytochemical characterization. J Histochem Cytochem (2006) 0.96
Transplanted neural stem/progenitor cells generate myelinating oligodendrocytes and Schwann cells in spinal cord demyelination and dysmyelination. Exp Neurol (2008) 0.96
Manufacture of poly(2-hydroxyethyl methacrylate-co-methyl methacrylate) hydrogel tubes for use as nerve guidance channels. Biomaterials (2002) 0.96
Repair of the injured spinal cord by transplantation of neural stem cells in a hyaluronan-based hydrogel. Biomaterials (2013) 0.95
Analysis of green fluorescent protein expression in transgenic rats for tracking transplanted neural stem/progenitor cells. J Histochem Cytochem (2005) 0.95
Immuno-polymeric nanoparticles by Diels-Alder chemistry. Angew Chem Int Ed Engl (2007) 0.95
Click chemistry functionalized polymeric nanoparticles target corneal epithelial cells through RGD-cell surface receptors. Bioconjug Chem (2009) 0.95
An injectable drug delivery platform for sustained combination therapy. J Control Release (2009) 0.94
Injectable intrathecal delivery system for localized administration of EGF and FGF-2 to the injured rat spinal cord. Exp Neurol (2005) 0.94
Chitin-based tubes for tissue engineering in the nervous system. Biomaterials (2005) 0.94
Retrograde axonal degeneration "dieback" in the corticospinal tract after transection injury of the rat spinal cord: a confocal microscopy study. J Neurotrauma (2007) 0.94
Poly(ethylene glycol) modification enhances penetration of fibroblast growth factor 2 to injured spinal cord tissue from an intrathecal delivery system. J Control Release (2010) 0.93
Concussion incidence and time lost from play in the NHL during the past ten years. Can J Neurol Sci (2008) 0.93
Calcium entry through L-type calcium channels is essential for neurite regeneration in cultured sympathetic neurons. J Neurotrauma (2004) 0.93
Functional immobilization of interferon-gamma induces neuronal differentiation of neural stem cells. J Biomed Mater Res A (2010) 0.93
Neural stem/progenitor cells differentiate in vitro to neurons by the combined action of dibutyryl cAMP and interferon-gamma. Stem Cells Dev (2009) 0.93
Bone formation on two-dimensional poly(DL-lactide-co-glycolide) (PLGA) films and three-dimensional PLGA tissue engineering scaffolds in vitro. J Biomed Mater Res A (2003) 0.92
Incorporation of protein-eluting microspheres into biodegradable nerve guidance channels for controlled release. J Control Release (2005) 0.92
Riluzole for the treatment of acute traumatic spinal cord injury: rationale for and design of the NACTN Phase I clinical trial. J Neurosurg Spine (2012) 0.92
Neural stem/progenitor cells from the adult human spinal cord are multipotent and self-renewing and differentiate after transplantation. PLoS One (2011) 0.92
A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repair. Tissue Eng Part A (2009) 0.92
Creating permissive microenvironments for stem cell transplantation into the central nervous system. Trends Biotechnol (2011) 0.92
Diels-Alder Click cross-linked hyaluronic acid hydrogels for tissue engineering. Biomacromolecules (2011) 0.92
Growth factor enhancement of peripheral nerve regeneration through a novel synthetic hydrogel tube. J Neurosurg (2003) 0.91
Extramedullary chitosan channels promote survival of transplanted neural stem and progenitor cells and create a tissue bridge after complete spinal cord transection. Tissue Eng Part A (2008) 0.91
Tunable growth factor delivery from injectable hydrogels for tissue engineering. J Am Chem Soc (2011) 0.91
Chemically-bound nerve growth factor for neural tissue engineering applications. J Biomater Sci Polym Ed (2003) 0.91
A hydrogel composite system for sustained epi-cortical delivery of Cyclosporin A to the brain for treatment of stroke. J Control Release (2013) 0.91
Concussion knowledge among medical students and neurology/neurosurgery residents. Can J Neurol Sci (2012) 0.91
Light-activated immobilization of biomolecules to agarose hydrogels for controlled cellular response. Biomacromolecules (2004) 0.91
Evaluation of clinical experience using cell-based therapies in patients with spinal cord injury: a systematic review. J Neurosurg Spine (2012) 0.91
Thrombin mediated migration of osteogenic cells. Bone (2005) 0.90
Fate of transplanted adult neural stem/progenitor cells and bone marrow-derived mesenchymal stromal cells in the injured adult rat spinal cord and impact on functional recovery. Surg Neurol (2008) 0.90
Controlled epi-cortical delivery of epidermal growth factor for the stimulation of endogenous neural stem cell proliferation in stroke-injured brain. Biomaterials (2011) 0.89
Hydrogel delivery of erythropoietin to the brain for endogenous stem cell stimulation after stroke injury. Biomaterials (2012) 0.89
Complete spinal cord transection treated by implantation of a reinforced synthetic hydrogel channel results in syringomyelia and caudal migration of the rostral stump. Neurosurgery (2006) 0.89
Fibrin gels containing GDNF microspheres increase axonal regeneration after delayed peripheral nerve repair. Regen Med (2013) 0.88
Novel intrathecal delivery system for treatment of spinal cord injury. Exp Neurol (2003) 0.88
Delayed implantation of intramedullary chitosan channels containing nerve grafts promotes extensive axonal regeneration after spinal cord injury. Neurosurgery (2008) 0.88
Intrathecal delivery of a polymeric nanocomposite hydrogel after spinal cord injury. Biomaterials (2010) 0.88
Consensus statement on concussion in sport--the 4th International Conference on Concussion in Sport held in Zurich, November 2012. PM R (2013) 0.88
Anisotropic three-dimensional peptide channels guide neurite outgrowth within a biodegradable hydrogel matrix. Biomed Mater (2006) 0.88